The content of this website in intended for healthcare professionals and healthcare policy makers in the United Kingdom and the Republic of Ireland. All content on this website has been funded and developed by CSL Seqirus unless otherwise specified.

Should we continue with 50–64 year old vaccination?

Dr Syed Ahmed & Professor Jonathan Van-Tam

20 August 2024

Dr Syed Ahmed and Professor Jonathan Van-Tam discuss the evidence for, benefits, risks and cost-efficacy of vaccinating the 50-to-64-year-old age group.

Related content

View all

  • Why do vaccines work?

Real-world evidence and randomised clinical trials for vaccines

4 October 2024

2:17

  • Influenza strains

Egg adaptation

11 September 2024

  • Influenza strains

Influenza strains Venn diagram

27 August 2024

Explore and learn: Categories

How to improve uptake

Influenza in society

Influenza strains

Perception of vaccines

Vaccination eligibility

Why do vaccines work?

Flu+ Forum

The Flu+ Forum is an annual meeting, organised and funded by CSL Seqirus, designed to bring together national experts and policy makers responsible for driving influenza vaccination programmes in the UK and Republic of Ireland.
Register

GBR-FLU-24-0065 | October 2024

The content of this website is intended for healthcare professionals and healthcare policy makers in the United Kingdom and the Republic of Ireland. All content on this website has been funded and developed by CSL Seqirus unless otherwise specified.

© CSL Seqirus 2024. All rights reserved.

This site is intended for UK and ROI healthcare professionals only.

To continue, please confirm that you are a UK or ROI healthcare professional by selecting one of the buttons below.

Yes, I am a UK or ROI healthcare professional

Yes

No, I am not a UK or ROI healthcare professional

No